| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in SGMT over the last quarter tilts toward selling: insiders offloaded a net 371,193 shares worth roughly $3.8M.
Classified under Biotechnology (Health Care sector), SGMT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 741.6K | $5.75M | - | |
| Other | 224.4K | $1.74M | - | |
| Other | 147.3K | - | - | |
| Dir | 62.2K | $395.3K | - | |
| CFO | 59.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Kemble George | Director | Sale+OE10b5-1 | 350,987 | $10.23 | $3,591,579.77 | -85.0% | - | - | |
| Aug 11, 2026 | Kemble George | Director | Sale+OE10b5-1 | 20,206 | $9.95 | $201,146.69 | -24.5% | - | - | |
| Jul 20, 2026 | Rozek Elizabeth | Chief Legal &Admin. Officer | Sell | 10,545 | $7.76 | $81,832.36 | -4.5% | +23.7% | - | |
| Jul 20, 2026 | Kemble George | Director | Sell10b5-1 | 18,844 | $7.46 | $140,529.13 | -23.3% | +23.7% | - | |
| Jul 20, 2026 | Happel David71 | President &CEO | Sell | 64,051 | $7.76 | $497,067.79 | -8.0% | +23.7% | - | |
| Feb 10, 2026 | Martins Eduardo Bruno | Chief Medical Officer | Sell | 3,640 | $5.36 | $19,511.13 | -3.4% | +36.3% | - | |
| Feb 10, 2026 | Happel David71 | President &CEO | Sell | 12,101 | $5.36 | $64,864.99 | -1.8% | +36.3% | - | |
| Feb 10, 2026 | Chauche Thierry | Chief Financial Officer | Sell | 1,312 | $5.36 | $7,032.71 | -7.7% | +36.3% | - | |
| Feb 10, 2026 | Rozek Elizabeth | Chief Legal &Admin. Officer | Sell | 2,622 | $5.36 | $14,054.44 | -1.4% | +36.3% | - | |
| Nov 20, 2025 | Kemble George | Executive Chairman | Sell10b5-1 | 37,688 | $7.69 | $289,979.01 | -31.8% | -27.8% | - |